(Solution) NU643 Week 10 Discussion 2: Groups Work on Pediatric Clinical Reference Tool


COURSE

NU643 ADVANCED PSYCHOPHARMACOLOGY


Overview

For this discussion, you will work in a group of two to three students to create a Pediatric Clinical Reference Tool for a disorder to be used in clinical practice and that can be shared with your peers. Please note, this discussion is not graded and is used as your tool of communication with your group.

  1. Each student will be randomly assigned to a group that is associated with a topic. Here is a list of the topics and their associated groups:
    • Topic 1: Generalized Anxiety (Group 1)
    • Topic 2: Depression (Group 2)
    • Topic 3: Bipolar Disorder (Group 3)
    • Topic 4: Autism Spectrum Disorder (Group 4)
    • Topic 5: Obsessive Compulsive Disorder (Group 5)
    • Topic 6: Schizophrenia/Psychotic Disorders (Group 6)
    • Topic 7: Aggression (Group 7)
    • Topic 8: Addiction (Group 8)
  2. Once you are placed in the groups, you can use this discussion forum to determine which method you will use to communicate within your groups. You may use Zoom, email, phone, or any other agreed upon method.
  3. Within your group, complete the Pediatric Clinical Template (PDF) to answer the following questions:
    • How does the topic present in children and, if applicable, how does that presentation differ in adults?
    • What are the treatment recommendations for children? Adolescents? (Use available resources including but not limited to linked treatment guidelines, The Carlat Child Psychiatry Report, UptoDate, etc..
    • Which treatment recommendations are off-label? FDA approved?
    • What are the relevant safety issues? (This may include risks associated with the topic or with the treatment.) Do these safety issues differ from adults?

SOLUTION

Safety Issues

 

The selection of appropriate treatment options is dependent on previous treatment history, patient preferences, and the treatment’s history of success. Same as child Some treatment options such as SSRIs and SNRIs have adverse effects, including nausea, agitation, weight gaining, insomnia and sexual pleasure problems (DeMartini et al., 2019).

Please click the icon below to access entire solution at $5